NCT01594658

Brief Summary

The venous ulcer due to venous insufficiency causes an important morbility to those people suffering from this condition. Most of therapies available under the obligatory health plan (POS, acronym in spanish) to date cover the cleaning of the ulcerous lesion and its medical handling using saline solutions, topical antibiotics and elastic dressings, implying an important intake from health resources due to its chronicity and the delay in ulcers healing, which usually takes periods ranging from 6 months to several years. therapeutical alternatives, which can guarantee optimal, fast and persistent in time healings, should be identified. The aim of this study is to determine the percentage of healing of active venous ulcers (using a clinical, etiological, anatomic and physiopathologic classification (CEAP), C6) following ultrasound-guided foam sclerotherapy of superficial venous reflux in patients with chronic venous ulceration after six months from the intervention, compared with conservative medical handling. The investigators expect that the ultrasound-guided foam sclerotherapy of superficial venous reflux will diminish the time of ulcer healing compared with standard handling.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

July 18, 2011

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 9, 2012

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
Last Updated

October 2, 2012

Status Verified

September 1, 2012

Enrollment Period

7 months

First QC Date

July 18, 2011

Last Update Submit

September 30, 2012

Conditions

Keywords

Ultrasound-guided foam sclerotherapy; chronic venous ulcers

Outcome Measures

Primary Outcomes (1)

  • Venous Ulcer Treatment with Foam Versus Conservative Treatment

    Number of participants with healing of venous ulcer after six months from the intervention.

    6 months

Study Arms (2)

Foam sclerotherapy

This arm corresponds to ultrasound-guided foam sclerotherapy of superficial venous reflux plus conservative management

Procedure: Foam sclerotherapy

Conservative

This arm only has medical standard handling (healings performed by the nurse group)

Procedure: conservative

Interventions

Foam application of 1% (Sklerol®, ICV Pharma, Bogota-Colombia), Reg INVIMA: 2002M-0001016, guided by ecography of insufficient superficial veins, doses from 10-40 cc of foam until obtaining endoluminal occlusion of the vein. The patient will rest for 8 minutes and then the leg will be covered with elastic bandage.

Also known as: (Sklerol®, ICV Pharma, Bogota-Col),Reg INVIMA: 2002M-0001016
Foam sclerotherapy
conservativePROCEDURE

This arm only has medical standard handling (healings performed by the nurse group)

Also known as: This arm only has medical standard handling
Conservative

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with C6 by CEAP Clasification

You may qualify if:

  • Presence of Venous Ulcer confirmed by CEAP C6
  • Chronic venous ulcer present for at least 4 weeks
  • Ankle-arm index greater or equal to 0.8 mmHg

You may not qualify if:

  • Severe hepatic, cardiac or pulmonary disease
  • Deep venous thrombosis
  • Active participation in other clinical trials

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Occidente de Kennedy

Bogota, Cundinamarca, Colombia

Location

Related Publications (2)

  • Pang KH, Bate GR, Darvall KA, Adam DJ, Bradbury AW. Healing and recurrence rates following ultrasound-guided foam sclerotherapy of superficial venous reflux in patients with chronic venous ulceration. Eur J Vasc Endovasc Surg. 2010 Dec;40(6):790-5. doi: 10.1016/j.ejvs.2010.08.011. Epub 2010 Sep 27.

    PMID: 20875753BACKGROUND
  • Darvall KA, Bate GR, Adam DJ, Silverman SH, Bradbury AW. Ultrasound-guided foam sclerotherapy for the treatment of chronic venous ulceration: a preliminary study. Eur J Vasc Endovasc Surg. 2009 Dec;38(6):764-9. doi: 10.1016/j.ejvs.2009.05.027. Epub 2009 Jul 18.

    PMID: 19616975BACKGROUND

MeSH Terms

Conditions

Varicose Ulcer

Interventions

Conservative Treatment

Condition Hierarchy (Ancestors)

Varicose VeinsVascular DiseasesCardiovascular DiseasesLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Miguel A Ramirez, MD

    Hospital Occidente de Kennedy

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
medical doctor

Study Record Dates

First Submitted

July 18, 2011

First Posted

May 9, 2012

Study Start

July 1, 2011

Primary Completion

February 1, 2012

Study Completion

September 1, 2012

Last Updated

October 2, 2012

Record last verified: 2012-09

Locations